ストックスクリーナーアプリを入手
40.00
0.23%
0.09
アフターアワーズ：
40.00
前日終値:
$39.91
開ける：
$39.9
24時間の取引高:
720.00K
Relative Volume:
1.18
時価総額：
$1.84B
収益：
$604.93M
当期純損益:
$-31.91M
株価収益率:
-16.53
EPS:
-2.42
ネットキャッシュフロー:
$45.67M
1週間 パフォーマンス:
+5.49%
1か月 パフォーマンス:
+16.58%
6か月 パフォーマンス:
+24.69%
1年 パフォーマンス:
-24.53%
1日の値動き範囲:
$39.27
$40.13
1週間の範囲:
$37.05
$40.28
52週間の値動き範囲:
$23.91
$55.63
Azenta Inc Stock (AZTA) Company Profile
AZTA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
40.00 | 1.84B | 604.93M | -31.91M | 45.67M | -2.42 |
|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-05 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-12-19 | 繰り返されました | Needham | Buy |
| 2025-10-30 | アップグレード | Jefferies | Hold → Buy |
| 2025-08-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2025-07-22 | 再開されました | Stephens | Equal-Weight |
| 2024-12-18 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | 開始されました | Jefferies | Hold |
| 2024-02-01 | 繰り返されました | B. Riley Securities | Buy |
| 2023-07-19 | 開始されました | Raymond James | Mkt Perform |
| 2023-05-10 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-03-31 | 再開されました | B. Riley Securities | Buy |
| 2022-03-21 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Azenta Inc (AZTA) 最新ニュース
Azenta, Inc. (AZTA) Stock Analysis: Exploring a 15.88% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Conestoga Capital Advisors LLC Sells 450,370 Shares of Azenta, Inc. $AZTA - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Azenta Delays 10-K Filing Due to Accounting Revisions - MSN
Why Azenta (AZTA) Got an Analyst Upgrade After Mixed Results and What It Implies for Automation - Sahm
Why Azenta Inc. stock is seen as undervalued2025 Big Picture & Community Verified Trade Alerts - Улправда
TD Cowen Raises Azenta (NASDAQ:AZTA) Price Target to $39.00 - MarketBeat
Azenta (AZTA) Analyst Rating Maintained, Price Target Raised to $39 by TD Cowen | AZTA Stock News - GuruFocus
Buyback Watch: How Azenta Inc. stock performs in rising dollar environmentTrade Analysis Summary & Low Drawdown Investment Strategies - Улправда
Market Outlook: Will Azenta Inc. stock deliver consistent dividendsJuly 2025 Chart Watch & Expert Approved Trade Ideas - Улправда
Azenta, Inc. (AZTA) Stock Analysis: Exploring a 19.81% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Why Are Azenta (AZTA) Shares Soaring Today - Finviz
Azenta Enters Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L. - citybiz
Allspring Global Investments Holdings LLC Cuts Stock Holdings in Azenta, Inc. $AZTA - MarketBeat
Azenta (NASDAQ:AZTA) Rating Increased to Buy at Wall Street Zen - MarketBeat
Bear of the Day: Azenta (AZTA) - The Globe and Mail
Vale and Azenta have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Azenta divests B Medical Systems to streamline portfolio - The Globe and Mail
Azenta enters agreement for sale of B Medical Systems to THELEMA for $63M - Yahoo Finance
Azenta to sell B Medical Systems business for $63 million By Investing.com - Investing.com Nigeria
Azenta Signs Sale And Purchase Agreement With Thelema - TradingView — Track All Markets
Azenta to sell B Medical Systems business for $63 million - Investing.com
Azenta (AZTA) to Divest B Medical Systems for $63 Million - GuruFocus
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L. - PR Newswire
Azenta (AZTA): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
How Azenta Inc. (BA3) stock stacks up against competitorsMarket Volatility Update & Big Returns, Small Investment - bollywoodhelpline.com
What analyst consensus implies for Azenta Inc. (BA3) stock2025 Price Momentum & Free Low Drawdown Momentum Trade Ideas - Улправда
Is Azenta’s Buyback and M&A Push Recalibrating the Investment Case For Azenta (AZTA)? - simplywall.st
Pharma News: Is Azenta Inc. stock a top pick in earnings seasonMarket Trend Report & Weekly High Potential Stock Alerts - moha.gov.vn
Needham Sticks to Their Buy Rating for Azenta (AZTA) - The Globe and Mail
Stock Market Recap: How Azenta Inc. stock performs after earningsJuly 2025 Technicals & Real-Time Buy Zone Alerts - Улправда
Azenta, Inc. ($AZTA) CEO 2025 Pay Revealed - Quiver Quantitative
How Azenta Inc. stock compares to industry benchmarksMarket Sentiment Review & Verified Short-Term Trading Plans - Улправда
Hedge Fund Moves: How strong is Azenta Inc. stock balance sheetJuly 2025 Highlights & Low Risk High Reward Ideas - Улправда
Form DEFR14A Azenta, Inc. - StreetInsider
Azenta (STU:BA3) EV-to-OCF : 16.73 (As of Dec. 19, 2025) - GuruFocus
Is Azenta Inc. stock a top pick in earnings seasonWeekly Stock Summary & Free Growth Oriented Trading Recommendations - Улправда
Azenta (NASDAQ:AZTA) Price Target Raised to $44.00 at Needham & Company LLC - MarketBeat
Azenta (AZTA): Needham Analyst Raises Price Target to $44 | AZTA Stock News - GuruFocus
Needham Raises Price Target on Azenta to $44 From $42, Keeps Buy Rating - marketscreener.com
Azenta, Inc. $AZTA Shares Sold by Squarepoint Ops LLC - MarketBeat
Will Azenta Inc. stock benefit from green energy trendsWeekly Profit Analysis & Verified Technical Signals - Bölüm Sonu Canavarı
How Azenta Inc. stock performs in rising dollar environmentSell Signal & Reliable Intraday Trade Alerts - Улправда
Azenta (NASDAQ: AZTA) outlines 2026 meeting, equity plan and governance - Stock Titan
Azenta, Inc. Announces Directors Not Nominated for Re-Election - marketscreener.com
How strong is Azenta Inc. stock balance sheetWeekly Trade Review & Accurate Buy Signal Notifications - Улправда
How Azenta Inc. stock benefits from tech adoptionTrade Exit Report & High Accuracy Swing Entry Alerts - Улправда
Azenta (AZTA) price target increased by 15.88% to 39.34 - MSN
Azenta, Inc. (NASDAQ:AZTA) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Azenta Inc (AZTA) 財務データ
収益
当期純利益
現金流量
EPS
Azenta Inc (AZTA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Lin Lawrence Y. | EVP, CFO and Treasurer |
Aug 11 '25 |
Buy |
27.96 |
2,500 |
69,900 |
46,013 |
| Hughes Violetta | VP, Chief Accounting Officer |
Feb 03 '25 |
Sale |
52.97 |
317 |
16,791 |
9,603 |
| Zhou Ginger | SVP and General Manager, Genom |
Jan 31 '25 |
Buy |
45.88 |
417 |
19,132 |
27,916 |
0.01%
1.19%
大文字化:
|
ボリューム (24 時間):